Literature DB >> 11985147

'Cultural safety' and the analysis of health policy affecting aboriginal people.

Vicki Smye1, Annette J Browne.   

Abstract

Vicki Smye and Annette Browne explore the exportability of the concept of 'cultural safety' from the healthcare literature in New Zealand to inform an analysis of mental health policy discourse affecting aboriginal communities in British Columbia, Canada. The moral issues raised are, they suggest, ones that nurses in research, policy and practice must attend to when providing health care to marginalised, disenfranchised populations.

Entities:  

Mesh：

Year:  2002        PMID： 11985147     DOI： 10.7748/nr2002.04.9.3.42.c6188

Source DB:  PubMed          Journal:  Nurse Res        ISSN： 1351-5578


  15 in total

1.  The United States Does CAIR About Cultural Safety: Examining Cultural Safety Within Indigenous Health Contexts in Canada and the United States.

Authors:  Francine Darroch; Audrey Giles; Priscilla Sanderson; Lauren Brooks-Cleator; Anna Schwartz; Darold Joseph; Roger Nosker
Journal:  J Transcult Nurs       Date:  2016-02-25       Impact factor: 1.959

2.  "They treated me like crap and I know it was because I was Native": The healthcare experiences of Aboriginal peoples living in Vancouver's inner city.

Authors:  Ashley Goodman; Kim Fleming; Nicole Markwick; Tracey Morrison; Louise Lagimodiere; Thomas Kerr
Journal:  Soc Sci Med       Date:  2017-01-26       Impact factor: 4.634

3.  Culturally Competent Service Provision Issues Experienced By Aboriginal People Living With HIV/AIDS.

Authors:  Kevin Barlow; Charlotte Loppie; Randy Jackson; Margaret Akan; Lynne Maclean; Gwen Reimer
Journal:  Pimatisiwin       Date:  2008

4.  Perceptions of Leadership: Comparing Canadian and Irish Physiotherapists' Views.

Authors:  Emer McGowan; Gillian Martin; Emma Stokes
Journal:  Physiother Can       Date:  2016       Impact factor: 1.037

5.  Advancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals.

Authors:  Ryan McNeil; Thomas Kerr; Bernie Pauly; Evan Wood; Will Small
Journal:  Addiction       Date:  2016-01-08       Impact factor: 6.526

6.  The Cedar Project: high incidence of HCV infections in a longitudinal study of young Aboriginal people who use drugs in two Canadian cities.

Authors:  Patricia M Spittal; Margo E Pearce; Negar Chavoshi; Wayne M Christian; Akm Moniruzzaman; Mary Teegee; Martin T Schechter
Journal:  BMC Public Health       Date:  2012-08-09       Impact factor: 3.295

7.  Patient and caregiver perspectives of health provision practices for First Nations and Métis women with gestational diabetes mellitus accessing care in Winnipeg, Manitoba.

Authors:  Hannah Tait Neufeld
Journal:  BMC Health Serv Res       Date:  2014-09-26       Impact factor: 2.655

8.  Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder.

Authors:  Heather Palis; Kirsten Marchand; Daphne Guh; Suzanne Brissette; Kurt Lock; Scott MacDonald; Scott Harrison; Aslam H Anis; Michael Krausz; David C Marsh; Martin T Schechter; Eugenia Oviedo-Joekes
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-05-19

9.  Innovations on a shoestring: a study of a collaborative community-based Aboriginal mental health service model in rural Canada.

Authors:  Marion A Maar; Barbara Erskine; Lorrilee McGregor; Tricia L Larose; Mariette E Sutherland; Douglas Graham; Marjory Shawande; Tammy Gordon
Journal:  Int J Ment Health Syst       Date:  2009-12-17

10.  The Cedar Project WelTel mHealth intervention for HIV prevention in young Indigenous people who use illicit drugs: study protocol for a randomized controlled trial.

Authors:  Kate Jongbloed; Anton J Friedman; Margo E Pearce; Mia L Van Der Kop; Vicky Thomas; Lou Demerais; Sherri Pooyak; Martin T Schechter; Richard T Lester; Patricia M Spittal
Journal:  Trials       Date:  2016-03-09       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.